Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, June 30, 2021
[ Wed, Jun 30th 2021
] - WOPRAI
[ Wed, Jun 30th 2021
] - WOPRAI
[ Wed, Jun 30th 2021
] - WOPRAI
[ Wed, Jun 30th 2021
] - WOPRAI
[ Wed, Jun 30th 2021
] - WOPRAI
[ Wed, Jun 30th 2021
] - WOPRAI
[ Wed, Jun 30th 2021
] - WOPRAI
Tue, June 29, 2021
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
[ Tue, Jun 29th 2021
] - WOPRAI
Mon, June 28, 2021
[ Mon, Jun 28th 2021
] - WOPRAI
[ Mon, Jun 28th 2021
] - WOPRAI
Joseph Stringer Maintained (APLS) at Strong Buy with Increased Target to $85 on, Jun 28th, 2021
Joseph Stringer of Needham, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $65 to $85 on, Jun 28th, 2021.
Joseph has made no other calls on APLS in the last 4 months.
There are 3 other peers that have a rating on APLS. Out of the 3 peers that are also analyzing APLS, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $39 on, Thursday, April 29th, 2021
These are the ratings of the 2 analyists that currently disagree with Joseph
- Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $82 on, Friday, May 21st, 2021
- Madhu Kumar of "Goldman Sachs" Initiated at Strong Buy and Held Target at $130 on, Friday, April 16th, 2021
